soul trial oral semaglutide cardiovascular outcomes results 2025 nejm Oral Semaglutide Reduces Cardiovascular Events in People with The SOUL Study - by
Pay in 4 interest-free payments of $6.74 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
























